When those valves weaken or fail, blood pools in the legs a condition called venous insufficiency
Customized dosing flexibility based on patient needs
This consistency is clinically important because GLP-1 drug levels must stay within a therapeutic window to suppress appetite and stabilize blood sugar without excess side effects
Comprehensive ePRO Portfolio: We have experience in supporting a wide range of ePRO measures to assess aspects of health important to patients with these diseases including: Health-related quality of life (HRQoL, e.g., SF-36, Impact of Weight on Quality of Life-Lite (IWQoL-Lite)(EQ-5D-5L), Food craving (e.g., Control of Eating Questionnaire (CoEQ)), Mental health (e.g., Columbia-Suicide Severity Rating Scale (C-SSRS), Patient Health Questionnaire-9 (PHQ-9)) and other measures such as the Patient Global Impression of Severity/Change (PCIS/C)
Phase 2 Type 2 Diabetes Trial The Lancet (2023) A parallel Phase 2 trial published in The Lancet assessed retatrutide in 281 participants with type 2 diabetes over 36 weeks
Eli Lilly TRIUMPH-4 topline, December 11, 2025 (Phase 3)
